Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review.

by Monica Franciosi, Giuseppe Lucisano, Emanuela Lapice, Giovanni F M Strippoli, Fabio Pellegrini, Antonio Nicolucci
Published 2013-01-01

Fundoplication After Heller Myotomy: A Retrospective Comparison Between Nissen and Dor

by Antonello Cuttitta, Antonio Tancredi, Angelo Andriulli, rmelinda De Santo, Andrea Fontana, Fabio Pellegrini, Roberto Scaramuzzi, Gerardo Scaramuzzi
Published 2011-12-01

Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials.

by Suetonia C Palmer, Ionut Nistor, Jonathan C Craig, Fabio Pellegrini, Piergiorgio Messa, Marcello Tonelli, Adrian Covic, Giovanni F M Strippoli
Published 2013-01-01

Epoch Analysis of On-Treatment Disability Progression Events over Time in the Tysabri Observational Program (TOP).

by Heinz Wiendl, Helmut Butzkueven, Ludwig Kappos, Maria Trojano, Fabio Pellegrini, Dominic Paes, Annie Zhang, Shibeshih Belachew, Tysabri® Observational Program (TOP) Investigators
Published 2016-01-01

Association between resistin levels and all-cause and cardiovascular mortality: a new study and a systematic review and meta-analysis.

by Andrea Fontana, Sara Spadaro, Massimiliano Copetti, Belinda Spoto, Lucia Salvemini, Patrizia Pizzini, Lucia Frittitta, Francesca Mallamaci, Fabio Pellegrini, Vincenzo Trischitta, Claudia Menzaghi
Published 2015-01-01

Visualizing the target estimand in comparative effectiveness studies with multiple treatments

by Gabrielle Simoneau, Marian Mitroiu, Thomas PA Debray, Wei Wei, Stan RW Wijn, Joana Caldas Magalhaes, Justin Bohn, Changyu Shen, Fabio Pellegrini, Carl de Moor
Published 2024-01-01

Time-Qualified Patterns of Variation of PPARγ, DNMT1, and DNMT3B Expression in Pancreatic Cancer Cell Lines

by Valerio Pazienza, Francesca Tavano, Massimo Francavilla, Andrea Fontana, Fabio Pellegrini, Giorgia Benegiamo, Vincenzo Corbo, Fabio Francesco di Mola, Pierluigi Di Sebastiano, Angelo Andriulli, Gianluigi Mazzoccoli
Published 2012-01-01

The burden of nephrotoxic drug prescriptions in patients with chronic kidney disease: a retrospective population-based study in Southern Italy.

by Ylenia Ingrasciotta, Janet Sultana, Francesco Giorgianni, Achille Patrizio Caputi, Vincenzo Arcoraci, Daniele Ugo Tari, Claudio Linguiti, Margherita Perrotta, Andrea Nucita, Fabio Pellegrini, Andrea Fontana, Lorenzo Cavagna, Domenico Santoro, Gianluca Trifirò
Published 2014-01-01

Mirna expression profiles identify drivers in colorectal and pancreatic cancers.

by Ada Piepoli, Francesca Tavano, Massimiliano Copetti, Tommaso Mazza, Orazio Palumbo, Anna Panza, Francesco Fabio di Mola, Valerio Pazienza, Gianluigi Mazzoccoli, Giuseppe Biscaglia, Annamaria Gentile, Nicola Mastrodonato, Massimo Carella, Fabio Pellegrini, Pierluigi di Sebastiano, Angelo Andriulli
Published 2012-01-01

Treatment Switching and Discontinuation Over 20 Years in the Big Multiple Sclerosis Data Network

by Jan Hillert, Melinda Magyari, Melinda Magyari, Per Soelberg Sørensen, Helmut Butzkueven, Helmut Butzkueven, Anneke Van Der Welt, Sandra Vukusic, Sandra Vukusic, Sandra Vukusic, Maria Trojano, Pietro Iaffaldano, Fabio Pellegrini, Robert Hyde, Leszek Stawiarz, Ali Manouchehrinia, Tim Spelman, Tim Spelman
Published 2021-03-01

Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes.

by Claudia Menzaghi, Simonetta Bacci, Lucia Salvemini, Christine Mendonca, Giuseppe Palladino, Andrea Fontana, Concetta De Bonis, Antonella Marucci, Elizabeth Goheen, Sabrina Prudente, Eleonora Morini, Stefano Rizza, Alyssa Kanagaki, Grazia Fini, Davide Mangiacotti, Massimo Federici, Salvatore De Cosmo, Fabio Pellegrini, Alessandro Doria, Vincenzo Trischitta
Published 2014-01-01

Low versus high dose erythropoiesis-stimulating agents in hemodialysis patients with anemia: A randomized clinical trial.

by Valeria Saglimbene, Suetonia C Palmer, Jonathan C Craig, Marinella Ruospo, Antonio Nicolucci, Marcello Tonelli, David Johnson, Giuseppe Lucisano, Gabrielle Williams, Miriam Valentini, Daniela D'Alonzo, Fabio Pellegrini, Paolo Strippoli, Mario Salomone, Antonio Santoro, Stefano Maffei, Jörgen Hegbrant, Gianni Tognoni, Giovanni F M Strippoli, CE-DOSE Study Investigators
Published 2017-01-01

Identification and functional characterization of three NoLS (nucleolar localisation signals) mutations of the CDC73 gene.

by Valerio Pazienza, Annamaria la Torre, Filomena Baorda, Michela Alfarano, Massimiliano Chetta, Lucia Anna Muscarella, Claudia Battista, Massimiliano Copetti, Dieter Kotzot, Klaus Kapelari, Dalia Al-Abdulrazzaq, Kusiel Perlman, Etienne Sochett, David E C Cole, Fabio Pellegrini, Lucie Canaff, Geoffrey N Hendy, Leonardo D'Agruma, Leopoldo Zelante, Massimo Carella, Alfredo Scillitani, Vito Guarnieri
Published 2013-01-01

Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS)

by Ellen M. Mowry, Robert A. Bermel, James R. Williams, Tammie L. S. Benzinger, Carl de Moor, Elizabeth Fisher, Carrie M. Hersh, Megan H. Hyland, Izlem Izbudak, Stephen E. Jones, Bernd C. Kieseier, Hagen H. Kitzler, Lauren Krupp, Yvonne W. Lui, Xavier Montalban, Robert T. Naismith, Jacqueline A. Nicholas, Fabio Pellegrini, Alex Rovira, Maximilian Schulze, Björn Tackenberg, Mar Tintore, Madalina E. Tivarus, Tjalf Ziemssen, Richard A. Rudick
Published 2020-08-01

Periodontitis and early mortality among adults treated with hemodialysis: a multinational propensity-matched cohort study

by Marinella Ruospo, Suetonia C Palmer, Germaine Wong, Jonathan C Craig, Massimo Petruzzi, Michele De Benedittis, Pauline Ford, David W Johnson, Marcello Tonelli, Patrizia Natale, Valeria Saglimbene, Fabio Pellegrini, Eduardo Celia, Ruben Gelfman, Miguel R Leal, Marietta Torok, Paul Stroumza, Anna Bednarek-Skublewska, Jan Dulawa, Luc Frantzen, Domingo del Castillo, Staffan Schon, Amparo G Bernat, Jorgen Hegbrant, Charlotta Wollheim, Letizia Gargano, Casper P. Bots, Giovanni FM Strippoli, on behalf of the ORALD Investigators
Published 2017-05-01

Predictors of treatment switching in the Big Multiple Sclerosis Data Network

by Tim Spelman, Tim Spelman, Melinda Magyari, Melinda Magyari, Helmut Butzkueven, Helmut Butzkueven, Anneke Van Der Walt, Anneke Van Der Walt, Sandra Vukusic, Sandra Vukusic, Sandra Vukusic, Maria Trojano, Pietro Iaffaldano, Dana Horáková, Jirí Drahota, Fabio Pellegrini, Fabio Pellegrini, Robert Hyde, Pierre Duquette, Jeannette Lechner-Scott, Jeannette Lechner-Scott, Seyed Aidin Sajedi, Patrice Lalive, Vahid Shaygannejad, Serkan Ozakbas, Sara Eichau, Raed Alroughani, Murat Terzi, Marc Girard, Tomas Kalincik, Francois Grand'Maison, Olga Skibina, Samia J. Khoury, Bassem Yamout, Maria Jose Sa, Oliver Gerlach, Yolanda Blanco, Rana Karabudak, Celia Oreja-Guevara, Ayse Altintas, Stella Hughes, Pamela McCombe, Radek Ampapa, Koen de Gans, Chris McGuigan, Aysun Soysal, Julie Prevost, Nevin John, Jihad Inshasi, Leszek Stawiarz, Ali Manouchehrinia, Lars Forsberg, Finn Sellebjerg, Anna Glaser, Luigi Pontieri, Hanna Joensen, Peter Vestergaard Rasmussen, Tobias Sejbaek, Mai Bang Poulsen, Jeppe Romme Christensen, Matthias Kant, Morten Stilund, Morten Stilund, Henrik Mathiesen, Jan Hillert, The Big MS Data Network: a collaboration of the Czech MS Registry, the Danish MS Registry, Italian MS Registry, Swedish MS Registry, MSBase Study Group, and OFSEP
Published 2023-12-01